Inovio Pharmaceuticals Inc (NASDAQ:INO)

During the Trading Day
8.34 -0.16 / -1.88%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.34 0.00 / 0.00%
Volume: 48.6K
Health Technology
Medical Specialties

Company Description

Inovio Pharmaceuticals, Inc. develops synthetic vaccines and immune therapies for cancers and infectious diseases. Its SynCon vaccines are generating immune responses with therapeutic T-cell responses exceeding other technologies in terms of magnitude, breadth and response rate. The company develops DNA vaccines, such as immune therapies to prevent or treat cancers, HIV, hepatitis C virus and other chronic infectious diseases. Inovio Pharmaceuticals was founded on June 29, 1983 and is headquartered in Blue Bell, PA.

Contact Information

Inovio Pharmaceuticals, Inc.
1787 Sentry Parkway West
Blue Bell Pennsylvania 19422-2200
P:(267) 440-4200
Investor Relations:
(858) 410-3101



Other institutional7.55%
Individual stakeholders6.03%
Mutual fund holders15.66%

Top Executives

J. Joseph KimPresident, Chief Executive Officer & Director
Niranjan Y. SardesaiChief Operating Officer
Peter D. KiesChief Financial Officer
Jessica LeeVice President-Clinical Operations
Mark L. BagarazziChief Medical Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.